The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler (338157)
ARTG Name
SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler
Product name
SALFLUMIX EASYHALER 250/50 fluticasone propionate/salmeterol (as xinafoate) 250ug/50ug Powder for inhalation Dry Powder Inhaler
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
fluticasone propionate
salmeterol xinafoate
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information